Comparison of Postoperative Nausea and Vomiting between Remimazolam and propofol in Pati ents Undergoing Oral and Maxillofacial Surgery

Comparison of Postoperative Nausea and Vomiting between Remimazolam and propofol in Pati ents Undergoing Oral and Maxillofacial Surgery : A Prospective Randomized Controlled Trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0006965

Enrollment

200

Registered

2022-01-26

Start date

2022-02-03

Completion date

Unknown

Last updated

2022-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : Both group undergoes total intravenous anesthesia. Propofol or remimazolam was randomly assigned as an anesthetic used for general anesthesia. Remimazolam group: intravenous continuous infusion

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients scheduled to undergo oral and maxillofacial surgery American Society of Anesthesiologist Physical Status (ASA PS) 1, 2

Exclusion criteria

Exclusion criteria: allergic history(propofol or any benzodiazepine drugs) poor general condition (American society of Anesthesiology Physical stauts(ASA PS) >3)

Design outcomes

Primary

Measure	Time frame
the incidence of postoperative nausea and vomiting	—

Secondary

Measure	Time frame
rescue antiemetics	—

Countries

Korea, Republic of

Contacts

Public ContactEun-Ji Choi

Pusan National University Dental Hospital

acej01@naver.com+82-55-360-5370

Outcome results